At AAIC 2018, we had the pleasure of speaking with Catherine Kaczorowski about the innovative work she is doing to accelerate drug discovery in Alzheimer’s disease.
Whilst at AAIC 2018, we spoke with Tom Russ about life course air pollution exposure and the significance of this on neurological disorders.
In this interview, we spoke with Giovanni Frisoni about his talk on gut microbiome alterations and what impact this research could have for patients.
In this interview, we spoke with Guido Bertolini about the first results from the CREACTIVE trial on circulating biomarkers in traumatic brain injury.
Whilst at FENS 2018, we spoke with Arnold Kriegstein on his work with cerebral organoids in brain development, and how we might define a cell’s maturity.
In this interview, Frank Bennett speaks to us about the work on IONIS-HTTRx in patients with early-stage Huntington’s disease and how this therapy could be applied to treat other neurodegenerative diseases.
In this interview, Matthew Hill speaks to us about how endocannabinoids could be a mechanism of comorbidity between inflammatory disease and anxiety.
In this interview, Marika tells us about her research on tissue clearing and imaging, including her opinion on what the biggest ‘hot topic’ in neurodegeneration is.
In this NCTalks podcast, Lauren Pulling speaks to Irene Tracey to hear more about her talk on imaging perception and lessons from pain, analgesia and anesthesia.
In this NCTalks podcast, Sharon Salt speaks to Wendy Weidner to learn more about Alzheimer’s Disease International and the global situation of dementia.